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The EndoglinPositive Sca-1Positive RhodamineLow Phenotype
Defines a Near-Homogeneous Population
of Long-Term Repopulating Hematopoietic Stem Cells
based on their differential efflux of the fluorescent dye
Hoechst 33342 (Goodell et al., 1996). More commonly,
mouse bone marrow HSCs can be enriched over 2000-
fold by FACS as a c-Kit positive, Sca-1 positive, Thy-
1.1 low, and lineage markers low or negative (c-KitPos
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2 Department of Biology Thy-1.1Pos Sca-1Pos LinNeg/Low -KTSL) population (Span-
grude et al., 1988). This cell population can be furtherMassachusetts Institute of Technology
Cambridge, Massachusetts 02142 separated into Rhodamine low (RhLow) and Rhodamine
high (RhHi) populations that define functionally distinc-
tive long-term repopulating HSCs (LTR-HSCs) and
short-term repopulating HSCs (STR-HSCs), respec-Summary
tively. As few as five KTSL-RhLow cells are capable of
reconstituting 65% of lethally irradiated recipientsEndoglin, an ancillary TGF- receptor, is differentially
expressed in long-term repopulating hematopoietic (Spangrude et al., 1995; Spangrude and Johnson, 1990).
In another example, single cells of the CD34Neg/Low c-KitPosstem cells (LTR-HSC). Here, we describe simple and
highly efficient purification schemes for mouse bone Sca-1Pos LinNeg/Low phenotype were capable of reconsti-
tuting all blood lineages of a lethally irradiated mousemarrow LTR-HSCs using Endoglin as a marker. The
Endoglin positive and Sca-1 positive (EndoPos Sca-1Pos) (Osawa et al., 1996).
While these procedures set the foundation for stempopulation, which contains about 36% of “Side Popu-
lation” (SP) cells, is highly enriched for LTR-HSCs. In cell purification and for further study of stem cell func-
tion, available sets of surface markers for HSC purifica-long-term competitive reconstitution assays, 100 such
cells reconstituted all lethally irradiated recipients. In- tion are far from optimal. The surface markers used for
positive selection, such as c-Kit, Sca-1, and Thy-1.1,terestingly, the EndoPos Sca-1Pos population contains
comparable LTR-HSC activity in both SP and non-SP are expressed on a broad population of hematopoietic
cells, thus limiting their efficiency in enrichment of LTR-fractions, indicating that many HSCs are not captured
by the SP phenotype. Furthermore, LTR-HSCs are ex- HSCs. Moreover, as judged from studies on mutant
mice, none of these markers are essential for HSC func-clusively found in the EndoPos Sca-1Pos LinNeg/Low (lineage
negative/low), but not in the EndoNeg Sca-1Pos LinNeg/Low tion, and expansion in culture of cells with these HSC
surface phenotypes does not correlate with expansionpopulation, suggesting that the EndoPos population
may contain all LTR-HSCs in mouse bone marrow. of HSC activity (Spangrude et al., 1995). Last, many of
these markers are not conserved between species orFinally, we demonstrated that the EndoPos Sca-1Pos
RhLow (Rhodamine-123 low) phenotype, without using during animal development (Jordan et al., 1990; Rebel
et al., 1996; Spangrude et al., 1988), thus further limitingCD34, c-Kit, or Lineage markers, defines a nearly ho-
mogenous population of LTR-HSCs. their uses.
Recent gene expression-profile analyses using a vari-
ety of highly enriched HSC populations revealed a col-Introduction
lection of genes that are differentially expressed in HSC
populations (Chen et al., 2002; Ivanova et al., 2002; Ra-The extraordinary ability of HSCs to self-renew and to
differentiate into all blood cell types (Abramson et al., malho-Santos et al., 2002). Differentially expressed cell
surface proteins could provide the basis of simpler and1977) was demonstrated by reconstitution of all blood
lineages by a single stem cell (Jordan and Lemischka, more specific LTR-HSC phenotypes that could be used
for their purification, or used as surrogate markers for1990; Osawa et al., 1996). This tremendous regenerative
capacity forms the basis of bone marrow transplanta- monitoring HSC activity in culture. Here we demonstrate
that Endoglin, an ancillary TGF- receptor, is a highlytion, which has broad clinical implications for treatment
of hematologic malignancies, nonmalignant blood cell specific HSC marker and can be used as the basis of a
simple and highly efficient purification scheme for adisorders, autoimmune diseases, and bone marrow fail-
ure states associated with cancer treatment. Many of near-homogeneous population of LTR-HSCs from
mouse bone marrow.these clinical applications are dependent on the identifi-
cation and purification of homogeneous HSC popula-
tions. Moreover, highly purified stem cells will provide a Results
starting point to understand the molecular mechanisms
that control HSC self-renewal and differentiation. EndoPos Sca-1Pos Cells Are Highly Enriched for the SP
Much effort has been devoted to the identification Phenotype and LTR-HSC Activity
and purification of HSCs—a rare population of cells To derive simple and effective LTR-HSC purification pro-
comprising about 1 in 105 mouse bone marrow cells cedures, we explored the use of Endoglin in combination
(Zhong et al., 1996). Mouse bone marrow HSCs can be with other known HSC surface markers such as c-Kit
enriched over 1000-fold as Side Population (SP) cells and Sca-1. Initially, we employed the SP phenotype as
a surrogate marker for LTR-HSCs because it defines a
cell population that is highly enriched for LTR-HSC activ-*Correspondence: lodish@wi.mit.edu
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Figure 1. EndoPos Sca-1Pos Cells Are Highly Enriched for the SP Phenotype and LTR-HSC Activity
(A–C) EndoPos Sca-1Pos cells are highly enriched for SP cells. FACS profile of Endoglin- and Sca-1-stained total bone marrow cells (A). SP
profile of total mouse bone marrow cells (B). SP profile of the EndoPos Sca-1Pos cell population (C). Percentages of cells with SP phenotype
are indicated.
(D–G) LTR-HSC activity in the EndoPos Sca-1Pos cell population. Long-term competitive reconstitution by 100 EndoPos Sca-1Pos cells (D). Multilin-
eage contribution by EndoPos Sca-1Pos cells at 14 weeks after transplantation (E). Quantitation of LTR-HSC frequency in the EndoPos Sca-1Pos
cell population by an in vivo limiting dilution assay (F). Long-term multilineage reconstitution by EndoPos Sca-1Pos cells in a secondary transplanta-
tion assay at 26 weeks after transplantation (G).
Each shaded bar represents the donor contribution to one recipient.
ity (Goodell et al., 1996). About 0.1% of bone marrow population the 20% of the cells that are positive for
Endoglin contain essentially all of the LTR-HSC activitycells are Endoglin and Sca-1 double positive (EndoPos
Sca-1Pos) cells (Figure 1A) and approximately 0.06% of (Chen et al., 2002). Thus, the EndoPos Sca-1Pos cells may
be enriched over 1000-fold for LTR-HSC activity.total bone marrow cells are in the SP fraction (Figure
1B). The frequency of SP cells is about 2, 3, and 5% Long-term competitive repopulation assays were
used to determine the LTR-HSC activity in the EndoPoswithin the gated cell populations that are positive for
c-Kit, Endoglin, or Sca-1, respectively (data not shown). Sca-1Pos cell population. One hundred EndoPos Sca-1Pos
cells (verified for containing 36% SP cells, but purifiedStrikingly, approximately 36% of EndoPos Sca-1Pos cells
are SP cells (Figure 1C), indicating an enrichment of SP without gating on the SP cells) repopulated all lethally
irradiated recipients for at least 6 months (Figure 1D),cells of about 600-fold ( 36/0.06) over that of total
bone marrow. We showed previously that within the SP and effectively reconstituted lymphoid and myeloid lin-
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Figure 2. Long-Term Competitive Reconstitution by SP or Non-SP Subset of the EndoPos Sca-1Pos Cells
Long-term competitive reconstitution by 100 EndoPos Sca-1Pos SP cells or 150 EndoPos Sca-1Pos non-SP cells (gates illustrated in Figure 1C).
Donor contribution by EndoPos Sca-1Pos SP cells (A). Multilineage contribution by EndoPos Sca-1Pos SP cells at 14 weeks after transplantation
(B). Donor contribution by EndoPos Sca-1Pos non-SP cells (C). Multilineage contribution by EndoPos Sca-1Pos non-SP cells at 14 weeks posttrans-
plantation (D).
Each shaded bar represents the donor contribution to one recipient.
eages (Figure 1E). This demonstrates that the frequency all LTR-HSCs are also SP cells. Of the EndoPos Sca-1Pos
cells, 36% are SP, and the remaining EndoPos Sca-1Posof LTR-HSCs in the EndoPos Sca-1Pos population is at
least 1 in 100 cells, thus suggesting that the EndoPos cells falling outside of the gate are considered non-SP
(Figure 1C). To determine the LTR-HSC activity in theSca-1Pos population is more than 1000-fold enriched for
LTR-HSC activity over that of total bone marrow. Fur- SP or the non-SP fractions of the EndoPos Sca-1Pos cells,
we transplanted 100 EndoPos Sca-1Pos SP cells or 150thermore, using an in vivo limiting dilution assay, we
determined that the frequency of LTR-HSCs in the En- EndoPos Sca-1Pos non-SP cells along with competitor
cells into lethally irradiated recipients. Interestingly, wedoPos Sca-1Pos population is about 1 per 28 cells (95%
confidence interval: 1 per 16 to 1 per 60 cells, Figure observed long-term multilineage reconstitution by both
the SP and the non-SP fractions of the EndoPos Sca-1Pos1F). Last, bone marrow cells from primary recipients
effectively reconstituted with 100 Ly5.1 EndoPos Sca-1Pos cells (Figures 2A–2D). The numbers of EndoPos Sca-1Pos
SP cells and EndoPos Sca-1Pos non-SP cells injected werecells at 26 weeks posttransplantation are capable of
long-term multilineage reconstitution of all the second- roughly proportional to their abundance in the EndoPos
Sca-1Pos population. Thus, the SP and non-SP fractionsary recipients at 6 months posttransplantation (Figure
1G). These results further demonstrate that EndoPos Sca- of the EndoPos Sca-1Pos population contain comparable
amounts of LTR-HSC activity.1Pos cells are enriched for LTR-HSCs that are capable
of self-renewal.
EndoPos Sca-1Pos LinNeg/Low Population Contains
Essentially All LTR-HSCs in Mouse Bone MarrowAbout Half of the LTR-HSCs in the EndoPos Sca-1Pos
Population Are Non-SP Cells FACS analysis of gated EndoPos Sca-1Pos cells revealed
that about 12% of EndoPos Sca-1Pos cells are negativeThe bone marrow Side Population is highly enriched for
LTR-HSCs (Goodell et al., 1996), but it is unclear whether for lineage marker expression (Figure 3A). Interestingly,
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Figure 3. FACS Analysis of Surface Antigen
Expression on EndoPos Sca-1Pos or LinNeg/Low
Bone Marrow Cells
(A and B) Heterogeneity of surface antigen
expression on EndoPos Sca-1Pos cells. Mouse
bone marrow cells were stained with antibod-
ies against Endoglin, Sca-1, c-Kit and a mix-
ture of lineage markers (CD3, Mac-1, Gr-1,
B220, and Ter-119). (A) Expression of a mix
of lineage-specific antigens on gated EndoPos
Sca1Pos population. An arbitrary LinNeg/Low gate
was set at 2.5% of total bone marrow cells
(not shown). (B) Expression of c-Kit on gated
EndoPos Sca1Pos population.
(C–F) FACS analysis of Endoglin, c-Kit, and
Sca-1 expression in lineage negative or low
mouse bone marrow cells. LinNeg/Low cells were
stained with antibodies against Endoglin,
c-Kit, and Sca-1. (C) c-Kit and Sca-1 expres-
sion in LinNeg/Low cells. (D) Expression of En-
doglin in c-kitPos Sca-1Pos LinNeg/Low cells. (E)
Endoglin and Sca-1 expression in gated
LinNeg/Low cells. (F) Expression of c-Kit in gated
EndoPos Sca-1Pos LinNeg/Low cells.
over 96% of EndoPos Sca-1Pos cells are c-Kit positive tion. At 4 weeks after transplantation, the donor contri-
bution by 300 EndoPos Sca-1Pos LinNeg/Low cells and 1800(Figure 3B). Further analysis showed that 7% of the
LinNeg/Low cells are c-KitPos Sca-1Pos (Figure 3C), and of or EndoNeg Sca-1Pos LinNeg/Low cells was comparable (Fig-
ure 4A). However, the contribution by EndoNeg Sca-1Posthese c-KitPos Sca-1Pos LinNeg/Low cells, 10% expressed
Endoglin (Figure 3D). In contrast, 1% of the LinNeg/Low LinNeg/Low cells diminished after 4 weeks while the contri-
bution by EndoPos Sca-1Pos LinNeg/Low cells increased dra-cells are EndoPos Sca-1Pos (Figure 3E), and of these
EndoPos Sca-1Pos LinNeg/Low cells, 85% expressed c-Kit matically (Figure 4A). The distinct reconstitution kinetics
support the notion that the EndoNeg Sca-1Pos LinNeg/Low(Figure 3F). Thus, these analyses suggest that LTR-HSC
activity may be further enriched from EndoPos Sca-1Pos population contains mostly STR-HSCs that can gener-
ate mature blood cells for only a few weeks. Significantpopulations by further enriching the LinNeg/Low subfrac-
tion. The use of c-KitPos as a marker will not provide long-term multilineage reconstitution was only seen in
mice that received EndoPos Sca-1Pos LinNeg/Low cells (Fig-significant enrichment of LTR-HSCs from EndoPos Sca-
1Pos populations (Figures 3B and 3F). Additionally, a pop- ures 4B and 4C). Furthermore, as determined by a lim-
iting dilution analysis, the frequency of LTR-HSCs isulation of LTR-HSCs appears to be negative for c-Kit
expression (Ortiz et al., 1999), suggesting that a more about 1 in 18 cells in the EndoPos Sca-1Pos LinNeg/Low popu-
lation (Figure 4D). The self-renewal potential of thecomplete stem cell population might be obtained by not
using c-Kit as a marker for further LTR-HSC enrichment. EndoPos Sca-1Pos LinNeg/Low cells was confirmed by their
ability to reconstitute secondary recipients (Figure 4E).To this end, we transplanted 300 EndoPos Sca-1Pos
LinNeg/Low cells or 1800 EndoNeg Sca-1Pos LinNeg/Low cells Taken together, these results demonstrate that EndoPos
Sca-1Pos LinNeg/Low cells are highly enriched for LTR-HSCinto lethally irradiated recipient mice. The numbers of
EndoPos Sca-1Pos LinNeg/Low cells and EndoNeg Sca-1Pos activity, and the EndoPos Sca-1Pos LinNeg/Low, but not the
EndoNeg Sca-1Pos LinNeg/Low population, contains essen-LinNeg/Low cells injected were roughly proportional to their
abundance in the Sca-1Pos LinNeg/Low bone marrow popula- tially all the LTR-HSCs in mouse bone marrow.
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Figure 4. EndoPos Sca-1Pos LinNeg/Low but Not EndoNeg Sca-1Pos LinNeg/Low Subset Contains Essentially All LTR-HSC Activity
(A) Donor contribution (% Ly5.1) by 300 EndoPos Sca-1Pos LinNeg/Low cells (solid orange line) or 1800 EndoNeg Sca-1Pos LinNeg/Low cells (dashed blue
line) at 4, 16, and 28 weeks after transplantation.
(B) Multilineage contribution (% chimerism) by EndoPos Sca-1Pos LinNeg/Low cells (orange bar) and EndoNeg Sca-1Pos LinNeg/Low cells (blue bar) at 16
weeks after transplantation.
(C) Competitive repopulating units (CRU) per 105 donor EndoPos Sca-1Pos LinNeg/Low cells (solid orange line) or EndoNeg Sca-1Pos LinNeg/Low cells
(dashed blue line) at 4, 16, and 28 weeks after transplantation.
(D) Quantitation of LTR-HSC frequency in the EndoPos Sca-1Pos LinNeg/Low cell population by an in vivo limiting dilution assay.
(E) Long-term multilineage reconstitution by EndoPos Sca-1Pos LinNeg/Low cells in a secondary transplantation (analyzed at 28 weeks after trans-
plantation).
Each colored bar represents the donor contribution to one recipient.
EndoPos Sca-1Pos RhLow Cells Are Negative or Low EndoPos Sca-1Pos RhLow Defines a Near-Homogeneous
LTR-HSC Populationfor Lineage Markers and CD34 Expression (LinNeg/Low
and CD34Neg/Low) To determine the enrichment of LTR-HSCs in the EndoPos
Sca-1Pos RhLow population, we transplanted 10 EndoPosWhile attempting to further enrich LTR-HSCs from the
EndoPos Sca-1Pos LinNeg/Low population using Rhodamine- Sca-1Pos RhLow cells or 100 EndoPos Sca-1Pos RhMed/Hi cells
together with 4  105 Sca-1-depleted supporting cells123 dye, we noted that the EndoPos Sca-1Pos RhLow pheno-
type, without using lineage markers, might define a into lethally irradiated recipients. Among the ten mice
that received 10 EndoPos Sca-1Pos RhLow cells, one diedhighly enriched LTR-HSC population. Our initial FACS
analyses revealed that the EndoPos Sca-1Pos RhLow pheno- within 2 weeks after transplantation. All nine survivors
showed significant donor contribution to myeloid andtype defines an extremely rare cell population—less than
1 in 105 total bone marrow cells (Figures 5A–5C). Specifi- lymphoid lineages at 4, 12, and 28 weeks posttrans-
plantation (Figures 6A and 6B). Clearly, 10 EndoPos Sca-cally, Rhodamine-123 dye staining divides total bone
marrow cells into the RhLow and RhHi populations (Figure 1Pos RhLow cells are sufficient to reconstitute all lymphoid
and myeloid lineages in nine of nine recipients for at5B). Since only 1% of EndoPos Sca-1Pos cells are RhLow
cells (Figure 5C), EndoPos Sca-1Pos RhLow cells comprise least 28 weeks. In contrast, only seven of the ten mice
that received 100 EndoPos Sca-1Pos RhMed/Hi cells showedless than 1 in 105 (1% of 0.1%) total bone marrow cells.
Strikingly, EndoPos Sca-1Pos RhLow cells are mostly LinNeg/Low long-term donor contribution to myeloid and lymphoid
lineages (Figures 6C and 6D).(Figures 5D and 5E) and CD34Neg/Low (Figures 5F and
5G). Since LTR-HSCs are known to be LinNeg/Low and Assuming that one recipient in ten is not reconstituted,
we estimate based on the Poisson probability distribu-CD34Neg/Low (Osawa et al., 1996; Spangrude et al., 1988),
this result implies that the rare EndoPos Sca-1Pos RhLow tion that the LTR-HSC frequency in the EndoPos Sca-1Pos
RhLow population is no less than 1 in 3 (95% confidencebone marrow cell population may be highly enriched for
LTR-HSCs and that the use of CD34 and lineage markers interval: 1 per 2 to 1 per 10 cells). In comparison, based
on repopulation of 7 of 10 mice that received 100 EndoPosfor negative selection will offer no significant further en-
richment. Sca-1Pos RhMed/Hi cells, we estimate that the LTR-HSC
Immunity
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Figure 5. EndoPos Sca-1Pos RhLow Cells Are LinNeg/Low and CD34Neg/Low
FACS profile of Endoglin and Sca-1 antigens on live bone marrow cells (A). FACS profile of Rhodamine-123- and Sca-1-stained live bone
marrow cells (B). Rhodamine-123 staining defines two distinctive cell populations, designated as Rhodamine low (RhLow) and Rhodamine
medium and high (RhMed/Hi) (B). Rhodamine-123 staining profile of EndoPos Sca-1Pos cells (C). Lineage staining profile of live bone marrow cells
(D) or EndoPos Sca-1Pos RhLow bone marrow cells (E). Arbitrary gates for lineage negative or low cells was set to exclude all but the lowest
stained 2% or 5% of live bone marrow cells, respectively. CD34 staining profile of live bone marrow cells (F), EndoPos Sca-1Pos cells (G), and
EndoPos Sca-1Pos RhLow cells (H).
frequency in this population is about 1 in 91 (95% confi- Discussion
dence interval: 1 per 59 to 1 per 140 cells). Furthermore,
the delayed reconstitution kinetics exhibited by the Through systematic analyses of LTR-HSC activity in
various bone marrow cell populations (see summary inEndoPos Sca-1Pos RhLow cells (Figure 6A)—little reconstitu-
tion at 4 weeks after transplantation—suggests that this Supplemental Table S1 [http://www.immunity.com/cgi/
content/full/19/4/525/DC1]), we demonstrated that En-population is largely devoid of short-term reconstituting
HSCs (Zhong et al., 1996). The self-renewal potential of doglin and Sca-1, without using lineage or other surface
markers, define a highly enriched LTR-HSC population.the EndoPos Sca-1Pos RhLow cells was further confirmed
by their ability to reconstitute all lineages in secondary Interestingly, the EndoPos Sca-1Pos population contained
a comparable amount of LTR-HSC activity in both SPrecipients (Figure 6E). Collectively, given that the homing
efficiency of injected stem cells is about 10% (Szilvassy and non-SP fractions, suggesting that the SP phenotype
does not capture all LTR-HSCs in mouse bone marrow.et al., 2003), the EndoPos Sca-1Pos RhLow phenotype de-
fines a homogenous or near-homogeneous population Moreover, we demonstrated that LTR-HSC activity re-
sides exclusively in the EndoPos Sca-1Pos LinNeg/Low butof LTR-HSCs from mouse bone marrow.
A Simple Phenotype for Hematopoietic Stem Cells
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Figure 6. EndoPos Sca-1Pos RhLow Cells Define a Near-Homogeneous LTR-HSC Population
Donor contribution by 10 EndoPos Sca-1Pos RhLow mouse bone marrow cells (A). Multilineage contribution by 10 EndoPos Sca-1Pos RhLow mouse
bone marrow cells at 28 weeks posttransplantation (B). Donor contribution by 100 EndoPos Sca-1Pos RhMed/Hi mouse bone marrow cells (C).
Multilineage contribution by 100 EndoPos Sca-1Pos RhMed/Hi mouse bone marrow cells at 28 weeks posttransplantation (D). Long-term multilineage
reconstitution by EndoPos Sca-1Pos LinNeg/Low cells in a secondary transplantation at 12 weeks after transplantation (E).
not the EndoNeg Sca-1Pos LinNeg/Low population. Finally, we functionally indistinguishable in their long-term multilin-
eage reconstitution potential, it is necessary to carrydemonstrated that the EndoPos Sca-1Pos RhLow phenotype
defines an extremely rare cell population (less than 1 in out secondary transplantation using subsequently sep-
arated SP and non-SP LTR-HSCs from the primary re-105 total nucleated bone marrow cells) that is also almost
exclusively LinNeg/Low and CD34Neg/Low, suggesting that this cipients to determine whether these two cell populations
are functionally identical in their self-renewal potential.population may be highly enriched for LTR-HSCs. In-
deed, the LTR-HSC frequency in EndoPos Sca-1Pos RhLow Endoglin may be a conserved functional marker for
LTR-HSCs. Endoglin is highly expressed on endothelialpopulation is no less than 1 in 3 cells, thus confirming
that the EndoPos Sca-1Pos RhLow phenotype defines a sim- cells and is known to play an important role in angiogen-
esis. Endoglin protein and its functions are conservedple and effective purification procedure for a near-
homogenous LTR-HSC population from mouse bone between mouse and human. Mutations in the endoglin
gene lead to haploinsufficiency and cause Hemorrhagicmarrow.
These results suggest that Endoglin may be a marker Telangiectasia Type 1 (HHT1) in human and mouse, a
disease characterized by bleeding due to vascular mal-for all LTR-HSCs in mouse bone marrow. Specifically,
the EndoPos cell fraction contains essentially all LTR- formations (Azuma, 2000). Gene targeting in mouse re-
vealed that Endoglin may play critical roles in vasculo-HSCs in the LinNeg/Low population of mouse bone marrow
cells (Figure 3). Since all LTR-HSCs in mouse bone mar- genesis and hematopoiesis (Arthur et al., 2000), but its
functions in regulating HSC self-renewal and differentia-row are LinNeg/Low, the EndoPos cell fraction likely contains
all LTR-HSCs in mouse bone marrow. Moreover, we tion are yet to be determined. Further transplantation
studies are required to determine whether Endoglin canfound that the EndoPos cell population contains LTR-
HSCs of both SP and non-SP phenotype. Consistent be used to enrich LTR-HSCs from different develop-
mental stages, from other mouse strains, or from spe-with this observation, loss of function of the ABCG2/
Bcrp1 gene, which is responsible for generating the SP cies other than mice. Nonetheless, we have shown that
Endoglin can be used to enrich repopulating HSCs fromphenotype, leads to significant reduction of repopulat-
ing SP cells but has no effects on mouse hematopoiesis common mouse strains such as C57/BL6 and FVB stains
(Chen et al., 2002). Endoglin is also found on a fraction(Zhou et al., 2002). Furthermore, we have found that
EndoPos Sca-1Pos non-SP cells can regenerate an EndoPos of human LTC-IC cells (Pierelli et al., 1998).
Finally, the LTR-HSC frequency in the EndoPos Sca-Sca-1Pos SP cell population that is indistinguishable from
that of wild-type animal (similar to Figure 1C, data not 1Pos RhLow cell population is at least comparable to that
reported for the KTSL-RhLow or CD34 Neg/Low c-KitPos Sca-shown). While our observation clearly indicates that SP
and non-SP LTR-HSCs from mouse bone marrow are 1Pos LinNeg/Low bone marrow cell populations (Osawa et al.,
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